首页/数据集/Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors

Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors

ChEBI2010-12-21 更新2026-07-21 收录

HIV疫苗开发

病毒载体免疫疗法

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-26239 数据链接链接失效反馈

官方服务：

资源简介：

Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors

应用场景：

创建时间：

2010-12-21

HIV疫苗开发

包膜蛋白

This study includes the development and characterization of a putative immunogen that resembles the HIV-1 native spike, is antigenically relevant and is able to produce broadly neutralizing antibodies

NIAID Data Ecosystem70

Further Developments of New Immunogenic Peptide-based HIV Vaccines Targeting Dendritic Cells, 2013

HIV疫苗开发

微针疫苗递送

HIV is a chronic infection that damages the immune system and eventually give immunodeficiency and disease. Today we have medications that slows the multiplication of the virus and turns the developme

DataCite Commons2023-02-28 更新30

Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies

HIV疫苗开发

中和抗体

BackgroundPrevious clinical efficacy trials failed to support the continued development of recombinant gp120 (rgp120) as a candidate HIV vaccine. However, the recent RV144 HIV vaccine trial in Thailan

NIAID Data Ecosystem20

Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-b.01 in complex with HIV fusion peptide (residue 512-519)

HIV疫苗开发

抗体-抗原复合物

Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-b.01 in complex with HIV fusion peptide (residue 512-519)

NIAID Data Ecosystem40

Summary of vaccine regimens.

疫苗佐剂研究

HIV疫苗开发

# QS-21 & 3D-MPL in o/w emulsion.*A: 92UG037 B: 92US715 Bal: Ba-L C:96ZM651 E: 93TH976.

Figshare2015-12-02 更新30